AstraZeneca PLC ( AZN) - Stock Earnings
AZN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 27, 2026, midnight | — / — | — | — / — | — |
AZN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 2.5 billion USD | 15.2 billion USD |
| 2025Q4 | 2.3 billion USD | 15.5 billion USD |
| 2026Q1 | 3.1 billion USD | 15.3 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AZN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.0 billion USD | 45.8 billion USD |
| 2024 | 7.0 billion USD | 54.1 billion USD |
| 2025 | 10.3 billion USD | 58.7 billion USD |
| 2026 Est. | — | — |
AZN
Price: $167.16
Dividend Yield: 1.68%
Forward Dividend Yield: 2.61%
Payout Ratio: 48.78%
Dividend Per Share: 4.30 USD
Earnings Per Share: 6.63 USD
P/E Ratio: 27.34
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Volume: 4.8 million
Ebitda: 1.8 billionMarket Capitalization: 294.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 34
DGR3: 2.65%
DGR5: 2.09%
DGR10: -4.71%
DGR20: 10.52%